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Abstract
A novel form of tetrameric streptavidin has been engineered to have reversible biotin binding capability. In wild-type
streptavidin, loop3–4 functions as a lid for the entry and exit of biotin. When biotin is bound, interactions between biotin and
key residues in loop3–4 keep this lid in the closed state. In the engineered mutein, a second biotin exit door is created by
changing the amino acid sequence of loop7–8. This door is mobile even in the presence of the bound biotin and can
facilitate the release of biotin from the mutein. Since loop7–8 is involved in subunit interactions, alteration of this loop in the
engineered mutein results in an 11u rotation between the two dimers in reference to wild-type streptavidin. The tetrameric
state of the engineered mutein is stabilized by a H127C mutation, which leads to the formation of inter-subunit disulfide
bonds. The biotin binding kinetic parameters (koff of 4.28610
24 s
21 and Kd of 1.9610
28 M) make this engineered mutein a
superb affinity agent for the purification of biotinylated biomolecules. Affinity matrices can be regenerated using gentle
procedures, and regenerated matrices can be reused at least ten times without any observable reduction in binding
capacity. With the combination of both the engineered mutein and wild-type streptavidin, biotinylated biomolecules can
easily be affinity purified to high purity and immobilized to desirable platforms without any leakage concerns. Other
potential biotechnological applications, such as development of an automated high-throughput protein purification
system, are feasible.
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Introduction
Wild-type streptavidin is a tetrameric protein with four identical
subunits. Each subunit has a biotin binding pocket and can bind
biotin tightly with a dissociation constant (Kd) around 10
214 M
[1]. This binding is considered to be irreversible and has been
applied in a wide range of biomedical and biotechnological
applications [2,3]. However, the tight biotin binding also makes
streptavidin not suitable for affinity purification of biotinylated
molecules. It would be ideal to develop engineered streptavidin
muteins with reversible biotin binding capability. These engi-
neered muteins can be applied to purify biotinylated molecules,
develop automated high-throughput protein purification systems,
reusable biosensor chips and bioreactors, study protein-protein
interactions and design strippable probing agents (e.g. engineered
muteins conjugated to horseradish peroxidase) for blot reprobing.
To understand the strategies applied in engineering streptavidin
with reversible biotin binding ability, it is vital to understand the
structural features of streptavidin, its biotin binding pocket and the
subunit interfaces. Each streptavidin subunit contains eight
antiparallel strands that form a b-barrel structure [4,5]. Two of
these subunits (A and B as well as C and D in Fig. 1b) have
extensive interfacial interactions to form a relatively stable dimer.
Two dimers then assemble into a tetramer via a weaker interface.
Although each subunit can bind a biotin molecule, each of the four
complete biotin pockets in the tetramer relies on the donation of
Trp-120 [6,7,8] located in loop7–8 from the neighboring subunit
(e.g. subunit A needs Trp-120 from subunit D and vice versa,
Figure 1b). Exceptionally tight biotin binding in streptavidin is
mainly contributed by three sets of interactions [9]. The first set
involves at least 6 residues (N23, S27, Y43, S88, T90 and D128) in
the biotin binding pocket to form an extensive hydrogen bonding
network with biotin. The second set involves strong hydrophobic
interactions [7] between biotin and four tryptophan residues (79,
92, 108 and 120). Finally, residues in loop3–4 (S45, V47, G48, N49
and A50) play a critical role in binding and trapping biotin to the
biotin binding pocket [10,11,12]. In the absence of biotin, loop3–4
has been shown to be flexible and is mainly in an open
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e35203configuration. However, after biotin binding, loop3–4 becomes
immobilized and is in a closed position (Figure 1, panels a and b)
because of its interactions with biotin. Furthermore, biotin binding
can also strengthen subunit interactions [13], in particular, via
interactions between biotin in one subunit and Trp-120 in loop7–8
from the neighboring subunit [6]. In fact, the majority of the
streptavidin-biotin complexes are in the tetrameric state in SDS-
polyacrylamide gel even if the samples have been boiled before
loading [14,15].
Two approaches have been taken to develop streptavidin
muteins with reversible biotin binding ability. The first approach is
to replace amino acid residues that are critical in hydrogen
bonding to biotin. Although these changes can indeed lower the
biotin binding affinities [16,17], many of the mutations also affect
inter-subunit interactions in the streptavidin tetramer. Weakening
inter-subunit interactions typically generates a heterogeneous
population of streptavidin oligomers which leads to many practical
problems. A second approach is to develop recombinant
monomeric streptavidin [18] which has lower biotin binding
affinity. This approach exploits the fact that an individual
streptavidin subunit lacks a complete biotin binding pocket since
Trp-120 from a neighboring subunit forms a key part of the
binding site (Figure 1, panels a and b). Replacing Trp-120 with
alanine (W120A) results in a tetrameric streptavidin mutein with a
Kd of 3610
29 M for biotin [17]. To create monomeric
streptavidin, charge repulsion and steric hindrance were intro-
duced at the subunit interface [18]. The resulting monomeric
streptavidin has a biotin binding constant around 10
27 M.
However, this mutein can be in the monomeric state only under
certain conditions. First, the salt concentration has to be low to
maximize electrostatic repulsion between streptavidin subunits.
Second, the concentration of the monomers has to be low as
exposure of the hydrophobic interface promotes non-specific
aggregation.
In this study, a new approach was designed to develop an
engineered tetrameric streptavidin with reversible biotin binding
capability and other desirable features.
Results
Rationale for the design of novel streptavidin muteins
Our novel approach relies on the effects of two loops (loop3–4
with residues 45–52 and loop7–8 with residues 114–121) on biotin
binding (Figure 1). Loop3–4 forms the lid and Trp-120 from loop7–
8 forms part of the wall of the biotin binding pocket. With various
hydrogen bonding and hydrophobic interactions in the biotin
binding pocket and the closure of the lid, biotin can hardly escape
from the binding pocket.
In this study, an attempt was made to create a dynamic ‘‘back
door’’ formed by loop7–8 in streptavidin to allow biotin a second
route to escape from the binding pocket when the ‘‘main door’’
primarily formed by loop3–4 is closed. This objective can
potentially be achieved by several approaches. One is to develop
a DW120 mutein. Since Trp-120 in loop7–8 is known to interact
Figure 1. Biotin entry and exit paths in wild-type streptavidin (panels a and b) and models of the engineered mobile loop7–8 in
streptavidin (panels c and d). Subunits A, B, C and D in wild-type streptavidin are colored in blue, red, yellow and green, respectively. Loop3–4 in
subunit D is in the open conformation as shown in panel a to allow biotin binding. Trp-120 (blue) from subunit A (blue) is required to form a complete
biotin binding pocket in subunit D (green). With biotin binding, loop3–4 is in the closed position as shown in panel b. To develop an engineered
streptavidin (8-aa-loop-H127C) with reversible biotin binding, loop7–8 in wild-type streptavidin was replaced by an engineered mobile loop to function
as a dynamic gateway for the exit of the bound biotin. The engineered mobile loop7–8 in subunit A is modeled in 10 different positions to illustrate its
dynamic nature (panel c). The blue loop (loop7–8) in the upper positions will form a wall as part of the biotin binding pocket for the subunit D (green). At
these stages, this gate isin theclosed state. When loop7–8is in the lower position(panels c andd), thegate isin theopenstate.With loop3–4in subunitD
in the closed conformation, biotin still can possibly escape from the biotin binding pocket at this stage (panel d).
doi:10.1371/journal.pone.0035203.g001
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modified loop7–8 to become more flexible. A second approach is to
create a mobile 8-amino-acid-loop (8-aa-loop) mutein in which
loop7–8 is engineered to have a completely different sequence but
retains the same length as the original loop in wild-type
streptavidin (Table 1). Asparagine and glycine were introduced
at the center of the loop since they are known to introduce a turn
in the loop structure [19]. The DSS (aspartate, serine and serine)
and SDG (serine, aspartate and glycine) sequences were
introduced to form the left and right arms of the loop, respectively
(Table 1). These amino acids were selected because they have a
high propensity for intrinsic disorder [20]. This design minimizes
interactions between loop7–8 and biotin, and was intended to allow
the engineered loop to act as an unlocked mobile door swinging
between the open and closed states even in the presence of biotin
(Figure 1, panels c and d). To improve the chance of obtaining a
mutein with its engineered ‘‘back door’’ open wide enough for the
exit of the bound biotin, a third approach was applied to create a
series of muteins (2-aa-loop, 4-aa-loop and 6-aa-loop muteins,
Table 1) with both the sequence of loop7–8 redesigned and the
length of the loop shortened. Muteins with shorter loops were
hypothesized to provide bigger openings around the biotin binding
pocket which should facilitate the release of biotin. In a
preliminary study, the 4-aa-loop mutein was immobilized on
agarose matrix. Although this matrix could bind biotinylated
proteins, streptavidin mutein was seen leaking from the column
during washing and elution. Since the coupling condition allows
on average one out of four subunits in the tetrameric streptavidin
mutein to be coupled to the matrix to maximize the accessibility of
the biotin binding sites, the leakage of streptavidin subunits
suggests that changes in the loop7–8 structure might result in
weakening of the inter-subunit interactions in the streptavidin
mutein. To avoid this complication, the H127C mutation [21,22]
was introduced to two constructs (8-aa-loop mutein and DW120
mutein) to create 8-aa-loop-H127C mutein and DW120-H127C
mutein, respectively. The H127C mutation has been reported
[21,22] to allow crosslink between subunits A and C (and also
between subunits B and D) through the formation of a disulfide
bond. These disulfide bonds can strengthen inter-subunit interac-
tions. Since the matrix for the 4-aa-loop mutein had a subunit
leakage problem, this mutein was not further characterized. The
remaining four muteins (DW120-H127C, 2-aa-loop, 6-aa-loop
and 8-aa-loop-H127C) were used for further analyses.
Production and purification of streptavidin muteins
To avoid the formation of inclusion bodies and the need to
refold the engineered streptavidin, all streptavidin muteins were
produced in their soluble state from B. subtilis via secretion [23].
The production yield of the muteins in a semi-defined medium
[24] was 40–60 mg/liter. Each mutein could be affinity purified in
one step using the biotin-agarose matrix. The purification of the 8-
aa-loop-H127C mutein showed typical results (Figure 2a). 8-aa-
loop-H127C mutein was efficiently captured by the biotin-agarose
matrix and could be eluted by buffer containing 4 mM biotin. The
recovery was ,90%. After dialysis to remove biotin from the
pooled elution fractions, the purified mutein could rebind the
biotin-agarose matrix and could be eluted again using biotin-
containing buffer (data not shown). This result demonstrates the
reversible biotin binding ability of the mutein.
Determination of kinetic parameters
The kinetic parameters for biotin binding to various muteins
were determined by surface plasmon resonance using the BIAcore
biosensor with biotinylated IgG proteins as the ligand (Table 2).
DW120-H127C had a binding affinity for biotin
(Kd=8.1610
29 M) that was comparable to that of the W120A
mutein (Kd,3610
29 M) [17]. Although muteins with smaller
loops (2- and 6-aa-loop muteins) were expected to have lower
biotin binding affinities, their binding affinities (,1–3610
29 M)
were actually comparable to that of the W120A mutein.
Streptavidin muteins with nano-molar binding affinity tend to
bind biotinylated molecules too tightly for affinity chromatography
purification, leading to the poor recovery of target proteins. The
mutein with the lowest biotin binding affinity (1.9610
28 M) in this
study is the 8-aa-loop-H127C mutein. It was further characterized
and its ability to act as an affinity agent for purifying biotinylated
proteins was explored.
Tetrameric state of 8-aa-loop-H127C mutein
Since the matrix with 4-aa-loop mutein immobilized showed
leakage of streptavidin subunits during chromatography, this
observation prompted the examination of the oligomeric state of
the 8-aa-loop-H127C mutein. The migration pattern of the 8-aa-
loop-H127C mutein resolved by SDS-PAGE was examined in the
presence or absence of mercaptoethanol under boiled and non-
boiled conditions (Figure 2b). 8-aa-loop mutein and wild-type
streptavidin were included in the study as a comparison. Since the
streptavidin inter-subunit interactions are weaker in the absence of
biotin [6], these analyses were performed in the absence of biotin.
Under all conditions, 8-aa-loop mutein migrated like a monomer.
By contrast, over 98% of wild-type streptavidin remained as
tetramers if the sample was not boiled. This suggests that changes
in the amino acid sequence of loop7–8 weaken inter-subunit
interactions. A significant difference in the oligomeric states of 8-
aa-loop and 8-aa-loop-H127C muteins was observed in the
absence of reducing agent. Whereas 8-aa-loop mutein remained
as monomers whether the sample was boiled or not, ,80% of 8-
aa-loop-H127C mutein remained in the dimeric form even after
boiling. This indicates the successful formation of disulfide bonds
between subunits. With the unboiled sample, most of 8-aa-loop-
H127C mutein adopted the tetrameric state. Since this mutein
exists mainly as tetramer even in the presence of detergent in SDS-
PAGE, it should be predominantly in the tetramer state under
non-denaturing conditions. Thus, the H127C mutation did
strengthen inter-subunit interactions in 8-aa-loop-H127C mutein.
Table 1. Features of the loop7–8 muteins.
Streptavidin Loop7–8 H127C
Wild-type L T S G113 TTEANAWKS122 TLV 2
DW120-H127C TTEANAK +
8-aa-loop-H127C DSSNGSDG +
8-aa-loop DSSNGSDG 2
6-aa-loop DSNGSG 2
4-aa-loop DNGG 2
2-aa-loop NG 2
The amino acid sequences in the natural and engineered loop7–8 loops are
shown in bold. The sequences flanking the loop7–8 are shown in black. + or 2
indicates the presence or absence of H127C in the muteins.
doi:10.1371/journal.pone.0035203.t001
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IgG using 8-aa-loop-H127C mutein-agarose matrix
To explore the feasibility of using 8-aa-loop-H127C mutein for
the affinity purification of biotinylated molecules, chemically
biotinylated protein G and IgG were captured on the 8-aa-loop-
H127C mutein-agarose matrix (Figure 3, panels a and b). After
removal of nonspecifically bound proteins, the bound biotinylated
proteins could be eluted from the column using 4 mM biotin.
Absence of a 20-kDa streptavidin band in the flow-through, wash
and elution fractions suggested that streptavidin subunit leakage
was not a problem. Estimation of the amount of IgG molecules
captured on the column and quantification of biotinylated IgG in
the elution fractions indicated the recovery to be approximately
95%. To demonstrate binding specificity, HeLa cell extracts were
applied to the column. Non-specific binding was not observed
(Figure 3c). Non-biotinylated protein G and IgG also could not
bind to the matrix (data not shown). When biotinylated IgG was
mixed with the HeLa cell extract, biotinylated IgG could be
affinity purified to homogeneity in one step (Figure 3d).
To regenerate the column for repeated rounds of purification,
the matrix was simply washed with 10 column volumes of binding
buffer. Using biotinylated BSA as the target protein for
purification, the 8-aa-loop-H127C mutein matrix saturated with
excess amounts of biotinylated BSA could be regenerated in this
manner to purify biotinylated BSA for 10 rounds with no
observable loss in binding capacity (data not shown).
Structural characterization of the 8-aa-loop-H127C
mutein
To assess the conformation of the 8-aa-loop-H127C mutein, the
protein was crystallized in the presence of biotin and its structure
was solved using X-ray crystallography. Using data extending to
2.0 A ˚ resolution, the structure clearly shows that the mutein
crystallizes as a tetramer with a single subunit in the asymmetric
unit (Figure S1). Biotin is bound in a manner indistinguishable
from that of wild-type streptavidin, but there is very little electron
density for loop7–8 (residues 114–121) and its neighboring residue
113 (Figure 4). The lack of electron density suggests that the
modified sequence of loop7–8 confers a significant degree of
dynamic disorder to the loop. The lack of interaction between
loop7–8 and the biotin molecule bound to the adjacent subunit
probably allows a higher level of mobility and dynamic motion in
this loop in the mutein.
Since inter-dimer interactions are critical for stabilizing the
tetrameric structure and will likely affect the dynamics of the
streptavidin tetramer, changes introduced to the 8-aa-loop-H127C
mutein can possibly affect the inter-dimer arrangement. In fact, a
significant alteration in the arrangement of subunits in the 8-aa-
loop-H127C mutein was observed when compared with wild-type
Figure 2. SDS-PAGE showing purification of 8-aa-loop-H127C mutein and its oligomeric state. In panel a, 8-aa-loop-H127C mutein was
affinity purified from B. subtilis culture supernatant using biotin-agarose matrix. S represents the concentrated culture supernatant before
purification. FT, W and E are the flow-through, wash and elution fractions, respectively. 5 ml from each fraction (800 ml per fraction, each fraction
contained the same volume of sample) was reduced with b–mercaptoethanol and boiled before loading onto the gel. The arrowhead marks the
position of the 8-aa-loop-H127C mutein. Panel b shows the tetrameric state of 8-aa-loop-H127C (MH127C). 8-aa-loop (M) and wild-type (wt)
streptavidin were included as reference. B and U represent the boiled and unboiled samples respectively. ME represents b–mercaptoethanol (used at
0.7 M final concentration). M shows the position of the molecular weight markers (numbers on the left of both panels are expressed in kDa).
doi:10.1371/journal.pone.0035203.g002
Table 2. Kinetic parameters of biotin binding in streptavidin muteins.
Streptavidin mutein DW120-H127C 2-aa-loop 6-aa-loop 8-aa-loop-H127C
ka or kon (M
21s
21) 4.96610
4 6.3610
4 2.43610
4 2.21610
4
kd or koff (s
21)4 . 0 610
24 7.02610
25 7.59610
25 4.28610
24
Kd (M) 8.1610
29 1.12610
29 3.13610
29 1.9610
28
tK (min)* 28.9 165 152 27
Biotinylated IgG proteins were immobilized to the sensor chip, and purified muteins were injected to determine binding affinities.
*tK is the half-life of biotin in the SAV-biotin complex. It is estimated based on the following equation: tK (min)=0.693/koff/60.
doi:10.1371/journal.pone.0035203.t002
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dimer appears to be very similar in nearly all of the previously
reported structures of biotin-bound streptavidin [4,5], partly
because loop7–8 in one dimer interacts with a bound biotin
molecule and nearby residues in the other dimer. Even when
biotin is not present, Trp-120 and Leu-124 form mostly non-
specific van der Waals contacts with Val-47 and Lys-121 from the
opposing dimer, respectively. Thus, previously reported structures
do not appear to have much difference in inter-dimer orientation
or interactions. In this case, the loss of order in loop7–8 of 8-aa-
loop-H127C mutein allows for a much larger rearrangement of
the A/B dimer relative to the C/D dimer. When the A/B dimer of
the mutein is superimposed onto the A/B dimer of wild-type
streptavidin, the C/D dimer is rotated by 11u relative to the
position of the C/D dimer in wild-type streptavidin (Figure 5). In
contrast, the relative positions of the two dimers in other structures
of biotin-bound streptavidin crystallized in different crystal forms
differ by ,1–3u. Significantly, an inter-dimer rotation of 5.4u was
reported in the first paper comparing the structure of apo-
streptavidin with biotin-bound streptavidin [4]. The even larger
inter-dimer rotation seen in the 8-aa-loop-H127C mutein supports
the correlation of a disrupted inter-dimer interface with less order
in loop7–8 and lower biotin-binding affinity.
An interesting feature also clearly seen in the crystal structure of
the 8-aa-loop-H127C mutein is that a disulfide bond is formed
between the Cys-127 residues of adjacent subunits at the A/B and
C/D dimer interfaces (Figure 6). The Cys residue was introduced
as a means of stabilizing the A/B and C/D dimers, based on the
observed proximity of His-127 residues in adjacent subunits of the
structure of wild-type streptavidin [4,5,21,22]. The formation of
Figure 3. Purification of biotinylated protein G and IgG using 8-aa-loop-H127C mutein-agarose matrix. Excess amounts of biotinylated
proteins were loaded to the column. Panel a: Biotinylated protein G with an apparent molecular mass of 37 kDa is marked by arrowhead. Some
biotinylated protein G molecules are in oligomeric state with higher molecular masses. Panel b: The 54- and 25-kDa protein bands are the
biotinylated heavy (marked by closed arrowhead) and light chains (marked by gray arrowhead) of IgG, respectively. Panel c: HeLa cell extract was
applied to the 8-aa-loop-H127C mutein-agarose matrix. Panel d: Biotinylated IgG mixed with HeLa cell extract. S: Sample before purification, FT, W,
and E: Flow-through, wash and elution fractions. M: Molecular weight markers.
doi:10.1371/journal.pone.0035203.g003
Figure 4. Electron density map (2|Fo|-|Fc| coefficients, con-
toured at 1.1 sigma) contoured around the region expected to
be occupied by residues 114–121 of loop7–8. The model for
residues 110–112 and 122–124 fit the electron density quite well, but
there is insufficient electron density to model residues 113–121. The
structure of wild-type streptavidin (PDB code 1SWE) is superimposed
and drawn in a thinner, gray line representation. Coefficients and
phases were calculated using Refmac and the figure was prepared
using PyMOL.
doi:10.1371/journal.pone.0035203.g004
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presence of disulfide-bonded protein in non-reducing SDS-PAGE
analysis as described above (Figure 2b).
Discussion
An idealized streptavidin mutein for affinity chromatography
applications should have the following desirable properties. First, it
should be tetrameric and all four biotin binding sites are capable of
binding biotin. In this state, the hydrophobic interface regions will
not be exposed to the surface, thus minimizing non-specific
hydrophobic interactions between the engineered streptavidin
mutein and proteins in the crude sample to be analyzed. Second,
intersubunit interactions should be strong. With one subunit of the
tetramer immobilized, the other three subunits should stably
associate with this covalently immobilized subunit so that no
streptavidin subunits will be stripped off the column during the
wash and elution steps. Third, the dissociation constant (Kd) for
biotin should be 10
27 to 10
28 M. Fourth, the off-rate (koff) for the
bound biotin in the streptavidin-biotin complex is ideally around
10
24 sec
21 to allow the estimated half-life of the bound biotin to
be around 10–30 minutes. With conditions 3 and 4 combined, the
interaction would be both strong and specific enough to allow non-
specifically bound molecules to be washed off the matrix without
leakage of the specifically bound biotinylated molecules. At the
same time, there should be efficient and quantitative elution of
biotinylated molecules from the column. A fine balance between
affinity towards biotinylated molecules and good recovery is
essential for the ideal streptavidin affinity agent. Fifth, the
engineered streptavidin muteins immobilized to the matrix should
be stable enough to allow the matrix to be used for multiple
rounds. Sixth, the engineered streptavidin should be produced
with a reasonable production yield in a soluble and functional state
without the requirement of refolding via inefficient and expensive
denaturation and renaturation processes. The engineered 8-aa-
loop-H127C mutein produced from B. subtilis via secretion meets
all of the above requirements.
Replacement of residues in loop7–8 of wild-type streptavidin
allows loop7–8 to become flexible and changes the relative
orientation of subunits in the tetrameric structure. These structural
changes can lead to the lowering of the biotin binding affinity in 8-
aa-loop-H127C mutein. Introduction of the H127C mutation is
for the objective to stabilize the mutein in the tetrameric state. To
confirm that loop replacement is the major factor contributing to
the observed lower biotin binding affinity in the 8-aa-loop-H127C
mutein, the kinetic parameters of the 8-aa-loop mutein (without
the H127C mutation) for binding biotinylated proteins were also
determined (data not shown). Its dissociation constant
(3.96610
28 M) was found to be comparable to that
(1.9610
28 M) of the 8-aa-loop-H127C mutein. In contrary, the
streptavidin mutein carrying solely the H127C mutation did not
show a significant decrease in biotin binding affinity since it could
not be eluted off from the biotin-agarose matrix using a biotin
containing buffer.
The strength of biotin interactions with wild-type streptavidin
and 8-aa-loop-H127C mutein was analyzed using the ligand
energy inspector function in the Molegro molecular viewer
program [25] based on X-ray crystallographic data. The binding
free energy is estimated by the MolDock scores as shown in
Table 3. The more negative values indicate stronger interactions.
This analysis suggests that the lower biotin binding affinity in 8-aa-
loop-H127C mutein is mainly contributed by both the absence of
interactions (i.e. W120 and K121) and weaker interactions (D128,
S45, N23 and L25) between biotin and residues in the biotin
binding pocket. A previous study also suggests that D128, S45 and
N23 play important roles in the biotin exit pathway [26].
Weakening the interactions between biotin and these residues is
Figure 5. Comparison of quaternary structures of the 8aa-loop-
H127C mutein and wild-type streptavidin (1SWE). Subunits A, B,
C and D are colored blue, cyan, red and orange for both the mutein and
wild-type structures. Biotin is drawn in space-filling representation and
colored black. In all panels, only subunits A and B have been aligned. As
a result, the cartoon diagrams and superimposed ribbon diagram at the
far right show how the C/D dimer of the mutein is rotated by ,10u
relative to the C/D dimer of wild-type streptavidin when the A/B dimers
of the mutein and wild-type streptavidin are superimposed. Loop7–8
(highlighted by the solid, black ovals in the front view) lies at the
interface between dimer A/B and dimer C/D of wild-type streptavidin
and is fixed in orientation in part by interactions between W120 and the
biotin molecule bound to the opposing dimer. Loop7–8 is dynamically
disordered in the mutein and hence is not shown in the cartoon model;
the expected location of loop7–8 is denoted by the dashed, black ovals
in the front view, and the location of the ends of the ordered parts of
both loops (residues 112 and 122) are denoted by small circles. The side
chains of Cys-127 from each subunit are drawn in space-filling
representation, showing the formation of disulfide bonds between
subunits A/C and B/D.
doi:10.1371/journal.pone.0035203.g005
Figure 6. Electron density map (2|Fo|-|Fc| coefficients, con-
toured at 1.1 sigma) contoured around the model of the
disulfide bond formed by Cys-127 residues from adjacent
subunits (A and C or B and D in the tetramer shown in Figure 5).
Coefficients and phases were calculated using Refmac and the figure
was prepared using PyMOL.
doi:10.1371/journal.pone.0035203.g006
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off rate (koff).
In addition to the interaction between biotin and specific
residues in the biotin binding pocket of streptavidin, the strength of
biotin binding appears to depend in part on the flexibility of
loop3–4 and loop7–8. In both wild-type streptavidin [10] and the
W120A mutein [7], both loops appear to be rigid in the presence
of biotin. In contrast, the flexibility and mobility of loop7–8 in 8-aa-
loop-H127C mutein creates a new exit path for the release of
biotin from the biotin binding pocket even if loop3–4 is closed. This
effect contributes to increases in the dissociation rate of the bound
biotin.
During the course of this study, a new streptavidin mutein called
traptavidin was reported [27]. Biotin dissociates from traptavidin
at least 10 times slower than from wild-type streptavidin and binds
with 10 times higher affinity. The crystal structure of traptavidin
[28] indicates that loop3–4 is well-ordered and adopts a closed
conformation in both the presence and absence of biotin. By
contrast, loop3–4 is well-ordered only when biotin is bound to wild-
type streptavidin. Because the conformation of the biotin-bound
complex in traptavidin is virtually identical to that seen in wild-
type streptavidin, the increase in biotin binding affinity is clearly
not due to additional contacts between biotin and traptavidin, as
supported by the analysis of binding interactions with Molegro,
which assigns similar MolDock scores for biotin binding to
traptavidin and wild-type streptavidin (2139.3 and 2140.1
respectively). The increased rigidity of loop3–4 thus accounts for
the higher biotin binding affinity in traptavidin. Conversely, the
increased mobility of the engineered loop7–8 in 8-aa-loop-H127
mutein may in part account for the observed lower biotin binding
affinity.
Most of the entire series of streptavidin muteins (DW120-
H127C, 2- and 6-aa-loop muteins) have biotin binding affinities
similar to that of the W120A mutein in the range of 10
29 M. Why
the 2- and 6-aa-loop muteins do not have lower biotin binding
affinities (Kd.10
28 M) is unclear at present, but the dynamics of
loop7–8 are likely important. Structural and molecular dynamics
studies of these muteins may help to explain relative binding
affinities.
Two matrices are commercially available to purify biotinylated
molecules. One is the monomeric avidin matrix [29]. Unfortu-
nately, this approach has three drawbacks. First, the production
cost is high as three avidin subunits are sacrificed for each avidin
subunit immobilized to the matrix. Second, the large hydrophobic
surface exposed in the generation of monomeric avidin typically
introduces problematic non-specific interactions with unwanted
proteins in the crude extract. Third, it is difficult to completely
denature the tetrameric avidin because of the strong subunit
interactions. Incomplete denaturation of avidin results in the
presence of some tetrameric avidin in the matrix which can bind
biotinylated molecules irreversibly. The second commercially
available matrix contains the engineered streptavidin mutein
[17]. The main concern with this matrix is the occasional
observation of leakage of streptavidin subunits during protein
loading, washing and elution. With the above-mentioned limita-
tions, the engineered 8-aa-loop-H127C mutein has substantial
advantages over the currently available matrices for affinity
purification of biotinylated molecules.
Many potential biotechnological applications of this mutein can
be developed. In the post-genomic era with the discovery of many
novel proteins which can be promising therapeutic targets,
biomarkers for diseases, and agents with medical and biotechno-
logical applications, the availability of a user-friendly high-
throughput system to purify and immobilize these proteins for
structural and functional studies is vital. However, protein
purification requires reversibility in binding while immobilization
requires ultra-tight interactions. Development of the 8-aa-loop-
H127C mutein provides a solution to solve this dilemma.
Biotinylated biomolecules can be affinity purified using the 8-aa-
loop-H127C mutein matrix and immobilized to the wild-type
streptavidin based protein chips. Furthermore, automated high-
throughput purification platforms, reusable biosensor chips,
protein arrays, bioreactors and magnetic beads can be developed
using the 8-aa-loop-H127C mutein. With the reversible biotin
binding capability, chemical conjugation or genetic fusion of 8-aa-
loop-H127C muteins with other proteins such as alkaline
phosphatase can allow blots to be reprobed without worrying
masking other probing sites because of steric hindrance imposed
by the bulky streptavidin conjugates.
Although the 8-aa-loop-H127C mutein in the present format
has many desirable features for biotechnological application, two
areas need further improvement. First, it would be ideal if its
production yield can be increased further (.60 mg/liter). Since
this mutein binds biotin reversibly, production of this mutein does
not exert any toxic effect on its expression host by depleting biotin
in both the cytoplasm and the culture medium. This is significantly
different from the production of wild-type streptavidin which
requires the production host to have the ability to produce
sufficient quantities of biotin to sustain the cell growth [24]. Many
other expression systems from prokaryotes to eukaryotes can now
be explored. Second, a hybrid tag containing six histidine residues
and a single cysteine residue [30] can be fused to either end of the
8-aa-loop-H127C mutein. When this mutein is produced at
industrial scale, a single-step purification using biotin-agarose
column is usually not sufficient to purify the mutein to
homogeneity. The added his-tag can offer another round of
Table 3. Interaction of biotin with residues in the biotin binding pocket of subunit A.
Protein 8-aa-loop-H127C Wild type SAV (2IZF) Difference (wild type – mutein)
MolDock score 2125.6 2140.1 214.4
Trp 120 (from subunit D) 0 210.5 210.5
Lys 121 (from subunit D) 0 21.3 21.3
Asp128 24.4 27.7 23.3
Ser 45 26.6 28.0 21.4
Asn 23 24.1 25.2 21.1
Leu 25 23.5 24.3 20.8
doi:10.1371/journal.pone.0035203.t003
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added cysteine residue in the tag can be applied for orientation
specific coupling of the mutein to the thiol-based coupling column
matrices, biosensor chips or protein arrays. This approach not
only improves the accessibility of the biotin binding sites of the
immobilized mutein in the affinity matrix [31] but also makes
chemical coupling of this mutein to various matrices in a user
friendly manner.
Materials and Methods
Construction of expression plasmids for production of
streptavidin muteins in B. subtilis
Plasmid pSSAV [23] carrying a B. subtilis levansucrase signal
peptide for secretion and a P43 promoter for transcription was
used as the expression vector. This vector carries a synthetic gene
for wild-type full-length streptavidin. To construct the expression
vectors for the loop muteins, the gene encoding the wild-type
streptavidin counterpart in pSSAV was replaced by the PstI/BclI
synthetic fragments encoding the loop muteins. E. coli pbluescript
plasmids containing the synthetic gene fragments were ordered
from Epoch Life Science, Inc. Texas, U.S.A. Each E. coli plasmid
was digested with PstI/BclI to release the synthetic gene fragment
which would then be ligated to the PstI/BclI cut pSSAV to
generate the expression vectors.
Production and affinity purification of streptavidin
muteins
B. subtilis WB800 [32] cells carrying the expression vectors were
cultivated in a semi-defined medium [24] at 30uC for 9–12 hours.
Culture supernatant was collected by centrifugation and strepta-
vidin muteins were affinity purified using biotin-agarose as
described previously [18].
X-ray crystallographic studies
Crystals of 8-aa-loop-H127C mutein were obtained using the
hanging-drop vapor diffusion technique by combining 2 mL
protein (4 mg/mL, 10 mM Tris-Cl pH 7.5, 150 mM NaCl) with
2 mL reservoir solution (50% Tacsimate, pH 6.0 (Hampton
Research), 10% (w/v) glycerol). Crystals grew to an approximate
size of 0.260.260.1 mm after ,2 weeks. They were suspended in
a microfabricated loop (Mitegen) and flash-cooled under a
nitrogen gas stream (,100 K, Oxford Cryosystems). Data were
measured using X-rays from a rotating anode generator (Rigaku
RU-H3R), Multilayer optics (Osmic Blue) and Mar345 imaging
plate detector (MarResearch). Diffraction data (200 images60.5u;
10 minutes/image) were indexed and scaled using DENZO and
Scalepack [33]. The space group was assigned by autoindexing,
inspecting systematic absences and scaling. It was confirmed to be
P42212 by molecular replacement calculations and refinement.
PHASER [34] was used for molecular replacement calculations,
yielding a single very strong solution using a single subunit of wild-
type streptavidin (1SWE) as the search model. Refinement
calculations were performed using REFMAC (v. 5.5.0109) [35],
and model building was performed using COOT (v. 0.6.1) [36].
Geometric parameters were monitored using Procheck [37] and
Molprobity [38]. Crystallographic statistics are reported in Table 4.
Analysis of interactions between biotin and streptavidin
using Molegro viewer
The pdb files of the biotin complexes associated with 8-aa-loop-
H127C mutein, wild-type streptavidin (2IZF) and traptavidin
(2Y3F) [28] were used as the input files. Each of these files was
imported to Molegro Molecular Viewer (Version 2.2.0) [25].
Interaction energy analysis was performed using the ligand energy
inspector module in the program. Before analysis, both the ligand
and protein hydrogen bonding positions were optimized and the
ligand was energy minimized using the action panel in the ligand
energy inspector module. The protein-ligand interaction energy
(Einter, sum of the steric interaction energy, hydrogen bonding
energy, short- and long-range electrostatic interaction energies)
was expressed in the form of the MolDock score [25] in arbitrary
units. A more negative value reflects a stronger interaction.
Other methods
Determination of kinetic parameters using BIAcore biosensor,
preparation of streptavidin-agarose matrix and purification of
biotinylated proteins were performed as previously described
[18,39]. The affinity column had a bed volume of 0.1 ml 8-aa-
loop-H127C mutein coupled matrix. 200 ml sample containing
0.2 mg of biotinylated protein G or 0.44 mg biotinylated IgG from
ThermoFisher was applied to the column. To purify biotinylated
IgG from a mixture, HeLa cell extract containing 0.6 mg protein
was mixed with 0.44 mg biotinylatyed IgG. This mixture was then
applied to the affinity column for purification. The graphic
drawings of the structure of the streptavidin-biotin complex shown
in Fig. 1 were generated by using the Yasara program [40],
(YASARA Biosciences GmbH, Austria). To model the possible
Table 4. Crystallographic statistics.
Data collection
Space Group
Mol/A.U. 1
Unit cell a, b, c (A ˚) 57.1, 57.1, 70.2
Resolution (A ˚)
a 20.021.95 (2.0221.95)
Rsym
b 0.063 (0.496)
I/sI 28.4 (2.75)
Completeness (%) 96.1 (88.0)
Redundancy 6.7 (3.6)
Refinement
Resolution (A ˚) 19.3922.00
Unique reflections 7585
Rwork
c/Rfree
d 0.189/0.232
No. of atoms 1003
Protein atoms 915
Biotin 16
Water 72
r.m.s.d. from ideal
e geometry
Bond lengths (A ˚) 0.009
Bond angles (u) 1.26
Ramachandran angles
f
%-favored 97.5%
%-outliers 0%
aValues from the outermost resolution shell are given in parentheses.
bRsym=Si|Ii2,I.|/Si Ii where Ii is the ith integrated intensity of a given
reflection and ,I. is the weighted mean of all measurements of I.
cRwork=S||Fo|2|Fc||/S|Fo| for 95% of reflection data used in refinement.
dRfree=S||Fo|2|Fc||/S|Fo| for 5% of reflection data excluded from refinement.
eRoot-mean-square deviations from ideal geometry calculated by Procheck [37].
fRamachandran plot analysis carried out using Molprobity [38].
doi:10.1371/journal.pone.0035203.t004
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complex was used as the input file. The amino acid residues (G113
and S122) at the base of loop7–8 were fixed. The possible
conformations of loop were searched against the protein data bank
using the loop modeling module in Yasara. Two modeled
structures with loops in the upper and lower positions were
selected as the input pdb files. These two input structures define
the boundary of the loop movement. A pdb file containing 10
modelled structures generated from the Morph server [41] website
was analyzed by Yasara to generate the animated structures shown
in Fig. 1c.
Supporting Information
Figure S1 A complete tetramer of the 8aa-loop-H127C mutein
is drawn, which each subunit drawn in a different color. The unit
cell is drawn as a black box. The two-fold axes running through
the origin are drawn according to standard crystallographic
conventions. Three orthogonal views are drawn: each view is
parallel to one of the three crystallographic axes. For each view,
the two remaining axes orthogonal to axis being viewed down are
labeled.
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